Marksans Pharma Limited (BOM:524404)

Marksans Pharma Statistics

Total Valuation

Marksans Pharma has a market cap or net worth of INR 102.44 billion. The enterprise value is 97.94 billion.

Market Cap	102.44B
Enterprise Value	97.94B

Important Dates

The last earnings date was Tuesday, February 11, 2025.

Earnings Date	Feb 11, 2025
Ex-Dividend Date	Sep 17, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.41%
Shares Change (QoQ)	-0.31%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	204.19M

Valuation Ratios

The trailing PE ratio is 27.81.

PE Ratio	27.81
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	4.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	26.59
EV / Sales	3.96
EV / EBITDA	18.93
EV / EBIT	22.73
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.09
Debt / EBITDA	0.38
Debt / FCF	n/a
Interest Coverage	32.97

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	11.94%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	21.69M
Profits Per Employee	3.23M
Employee Count	1,141
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +45.98% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+45.98%
50-Day Moving Average	266.90
200-Day Moving Average	244.60
Relative Strength Index (RSI)	37.41
Average Volume (20 Days)	99,008

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Marksans Pharma had revenue of INR 24.74 billion and earned 3.68 billion in profits. Earnings per share was 8.13.

Revenue	24.74B
Gross Profit	13.55B
Operating Income	4.31B
Pretax Income	4.88B
Net Income	3.68B
EBITDA	4.93B
EBIT	4.31B
Earnings Per Share (EPS)	8.13

Balance Sheet

The company has 6.72 billion in cash and 1.98 billion in debt, giving a net cash position of 4.74 billion.

Cash & Cash Equivalents	6.72B
Total Debt	1.98B
Net Cash	4.74B
Net Cash Per Share	n/a
Equity (Book Value)	23.05B
Book Value Per Share	50.24
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 54.76%, with operating and profit margins of 17.41% and 14.89%.

Gross Margin	54.76%
Operating Margin	17.41%
Pretax Margin	19.73%
Profit Margin	14.89%
EBITDA Margin	19.92%
EBIT Margin	17.41%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 0.27%.

Dividend Per Share	0.60
Dividend Yield	0.27%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	-0.41%
Shareholder Yield	-0.15%
Earnings Yield	3.60%
FCF Yield	n/a

Stock Splits

The last stock split was on March 11, 2008. It was a forward split with a ratio of 10.

Last Split Date	Mar 11, 2008
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a